Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-001621

ChemoCentryx, Inc. · CCXI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas J. Schall
Officer — President and CEO · Director
Period of report
Jan 1, 2019
Accepted (ET)
Jan 3, 2019 · 9:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 1, 2019M33,334$0.00A2,218,328D
Common StockJan 1, 2019M33,333$0.00A2,251,661D
Common StockJan 1, 2019M30,000$0.00A2,281,661D
Common StockF4Jan 1, 2019F52,806$10.91D2,228,855D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF5,F6—Jan 1, 2019M33,334D——Common Stock33,3340D
Restricted Stock UnitsF5,F7—Jan 1, 2019M33,333D——Common Stock33,33333,334D
Restricted Stock UnitsF5,F8—Jan 1, 2019M30,000D——Common Stock30,00060,000D

Explanation of responses